FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Paclitaxel is used to treat breast cancers, but the mechanisms by which it induces apoptosis are poorly understood. Consequently, we have studied the role of the FoxO transcription factors in determining cellular response to paclitaxel. Western blotting revealed that in a panel of nine breast cancer cell lines expression of FoxO1a and FoxO3a correlated with the expression of the pro-apoptotic FoxO target Bim, which was associated with paclitaxel-induced apoptosis. In MCF-7 cells, which were paclitaxel-sensitive, the already high basal levels of FoxO3a and Bim protein increased dramatically after drug treatment, as did Bim mRNA, which correlated with apoptosis induction. This was not observed in MDA-231 cells, which expressed low levels of FoxOs and Bim. Gene reporter experiments demonstrated that in MCF-7 cells maximal induction of Bim promoter was dependent on a FoxO binding site, suggesting that FoxO3a is responsible for the transcriptional up-regulation of Bim. Gene silencing experiments showed that small interference RNA (siRNA) specific for FoxO3a reduced the levels of FoxO3a and Bim protein as well as inhibited apoptosis in paclitaxel-treated MCF-7 cells. Furthermore, siRNA specific for Bim reduced the levels of Bim protein and inhibited apoptosis in paclitaxel-treated MCF-7 cells. This is the first demonstration that up-regulation of FoxO3a by paclitaxel can result in increased levels of Bim mRNA and protein, which can be a direct cause of apoptosis in breast cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The suppression of the AKT pathway activates downstream FoxO3a, resulting in the restoration of Bim transcriptional induction by FoxO3a [45, 46].”
Citations
Cites
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
Self-citationBouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Self-citationBiggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
Lei, K., & Davis, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438011100 · Cited by 1,068
Puthalakath, H., Huang, D. C. S., O’Reilly, L. A., King, S. M., & Strasser, A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80456-6 · Cited by 1,054
Dijkers, P. F., Medema†, R. H., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00728-4 · Cited by 976
Self-citationPhosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954
Research works printed but not linked: 3
- Page, 2000, Int. J. Oncol., 17, 23
- Tanabe, 2003, Int. J. Oncol., 22, 875
- Clark, 2002, Mol. Cancer Ther., 1, 707
Cited by
Items 101–200 of 540
McCarty, M. F., & Block, K. I. (2006) · Integrative Cancer Therapies · doi:10.1177/1534735406291499 · Cited by 109
Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition
Hamza, M., & Dionne, R. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010001 · Cited by 108
Olmos, Y., Brosens, J. J., & Lam, E. W. ‐. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.001 · Cited by 107
Self-citationLindner, A. U., Concannon, C. G., Boukes, G. J., Cannon, M. D., Llambi, F., Ryan, D., Boland, K., Kehoe, J., McNamara, D. A., Murray, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2269 · Cited by 105
“In the absence of genotoxic stress , no functional BH3 - only proteins BIM , PUMA , and NOXA were assumed to be present .”
BackgroundInfluentialPerturbing mitosis for anti‐cancer therapy: is cell death the only answer?
Haschka, M. D., Karbon, G., Fava, L. L., & Villunger, A. (2018) · EMBO Reports · doi:10.15252/embr.201745440 · Cited by 105
Identification of the prosurvival activity of nerve growth factor on cardiac myocytes
Caporali, A., Sala‐Newby, G. B., Meloni, M., Graiani, G., Pani, E., Cristofaro, B., Newby, A. C., Madeddu, P. R., & Emanueli, C. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402263 · Cited by 105
STAT3 Mediates Resistance to MEK Inhibitor through MicroRNA miR-17
Dai, B., Meng, J., Peyton, M., Girard, L., Bornmann, W. G., Ji, L., Minna, J. D., Fang, B., & Roth, J. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3647 · Cited by 103
Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Kontos, C. K., Christodoulou, M., & Scorilas, A. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990091 · Cited by 103
Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
Gomes, A., Brosens, J. J., & Lam, E. W. ‐. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6920 · Cited by 102
Self-citationKrol, J., Francis, R. E., Albergaria, A., Sunters, A., Polychronis, A., Coombes, R. C., & Lam, E. W. ‐. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0507 · Cited by 102
Self-citationNho, R. S., Hergert, P. J., Kahm, J., Jessurun, J., & Henke, C. A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.020 · Cited by 101
Apoptotic Pathways in Tumor Progression and Therapy
Melet, A., Song, K., Bucur, O., Jagani, Z., Grassian, A. R., & Khosravi‐Far, R. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_4 · Cited by 99
Tang, Y., Li, X., Liu, Z., Simoneau, A. R., Xie, J., & Zi, X. (2010) · International Journal of Cancer · doi:10.1002/ijc.25210 · Cited by 99
FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage
Chung, Y. M., Park, S.-H., Tsai, W.-B., Wang, S.-Y., Ikeda, M.-A., Berek, J. S., Chen, D. J., & Hu, M. C.-T. (2012) · Nature Communications · doi:10.1038/ncomms2008 · Cited by 98
Biswas, S. C., Shi, Y., Sproul, A., & Greene, L. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702634200 · Cited by 96
Mechanism of metastasis suppression by luteolin in breast cancer
Cook, M. T. (2018) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s144202 · Cited by 96
Cross-talk between IGF-I and TGF-β signaling pathways
Danielpour, D., & SONG, K. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.007 · Cited by 96
Kütük, Ö., & Letai, A. G. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.41 · Cited by 96
BH3-only protein BIM: An emerging target in chemotherapy
Shukla, S., Saxena, S., Singh, B. K., & Kakkar, P. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.09.002 · Cited by 94
Butt, A. J., Roberts, C. G. P., Seawright, A. A., Oelrichs, P. B., MacLeod, J. K., Liaw, T. Y. E., Kavallaris, M., Somers‐Edgar, T. J., Lehrbach, G. M., Watts, C. K. W., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0170 · Cited by 92
CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma
Murray, M. E., Gavile, C. M., Nair, J. R., Koorella, C., Carlson, L. M., Buac, D., Utley, A., Chesi, M., Bergsagel, P. L., Boise, L. H., et al. (2014) · Blood · doi:10.1182/blood-2013-10-530964 · Cited by 91
Gomes, A., Zhao, F., & Lam, E. W. ‐. (2013) · 癌症:英文版 · doi:10.5732/cjc.012.10277 · Cited by 91
Self-citationMolitoris, J. K., McColl, K. S., & Distelhorst, C. W. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0402 · Cited by 89
Pawar, V. K., Panchal, S. B., Singh, Y., Meher, J. G., Sharma, K., Singh, P. K., Bora, H. K., Singh, A., Datta, D. B., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.010 · Cited by 88
FoxO3 and oxidative stress: a multifaceted role in cellular adaptation
Bernardo, V. S., Torres, F. F., & da Silva, D. G. H. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02281-5 · Cited by 88
She, D. T., Wong, L. J., Baik, S., & Arumugam, T. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1058-0 · Cited by 87
de Moraes, G. N., Bella, L., Zona, S., Burton, M. J., & Lam, E. W. ‐. (2016) · Current Drug Targets · doi:10.2174/1389450115666141122211549 · Cited by 86
Self-citationGuan, H., Song, L., Cai, J., Huang, Y., Wu, J., Yuan, J., Li, J., & Li, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019946 · Cited by 86
Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer
Zhao, J., Xiao, Z., Li, T., Chen, H., Yuan, Y., Wang, Y., Hsiao, C.-H., Chow, D. S., Overwijk, W. W., & Li, C. (2018) · ACS Nano · doi:10.1021/acsnano.8b02481 · Cited by 84
Sense and Sensitivity: FOXO and ROS in Cancer Development and Treatment
Myatt, S. S., Brosens, J. J., & Lam, E. W. ‐. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3383 · Cited by 83
Self-citationNova1 is a master regulator of alternative splicing in pancreatic beta cells
Villate, O., Turatsinze, J.-V., Mascali, L. G., Grieco, F. A., Nogueira, T. C., Cunha, D. A., Nardelli, T. R., Sammeth, M., Salunkhe, V. A., Esguerra, J. L. S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku861 · Cited by 82
Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
Yang, J.-Y., & Hung, M. (2011) · Current Drug Targets · doi:10.2174/138945011796150299 · Cited by 82
Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
Zhao, Y., Tindall, D. J., & Huang, H. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8389 · Cited by 81
FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
Habashy, H. O., Rakha, E. A., Aleskandarany, M. A., Ahmed, M. A. H., Green, A. R., Ellis, I. O., & Powe, D. G. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1161-z · Cited by 81
Astanehe, A., Finkbeiner, M., Hojabrpour, P., To, K., Fotovati, A., Shadeo, A., Stratford, A. L., Lam, W. L., Berquin, I. M., Duronio, V., et al. (2009) · Oncogene · doi:10.1038/onc.2009.81 · Cited by 81
Li, Z., Zhang, J., Liu, Z., Cw, W., & Cj, T. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401983 · Cited by 80
Neuropilin-1 Modulates p53/Caspases Axis to Promote Endothelial Cell Survival
Wang, L., Dutta, S. K., Kojima, T., Xu, X., Khosravi‐Far, R., Ekker, S. C., & Mukhopadhyay, D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001161 · Cited by 79
Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim
Meng, J., Fang, B., Liao, Y., Chresta, C. M., Smith, P. D., & Roth, J. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013026 · Cited by 78
Fu, G., & Peng, C. (2011) · Oncogene · doi:10.1038/onc.2011.127 · Cited by 78
Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells
Carbajo‐Pescador, S., Steinmetz, C., Kashyap, A., Lorenz, S., Mauriz, J. L., Heise, M., Galle, P. R., González‐Gallego, J., & Strand, S. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.563 · Cited by 77
Goto, T., Takano, M., Hirata, J., & Tsuda, H. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604279 · Cited by 76
Programmed cell death of dendritic cells in immune regulation
Chen, M., & Wang, J. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00916.x · Cited by 75
Review on cancer and anticancerous properties of some medicinal plants
Sharma, H., Parihar, L., & Parihar, P. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9001089 · Cited by 75
Li, Z., Zhang, H., Chen, Y., Li, F., & Fang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291708 · Cited by 74
RACK1 and CIS Mediate the Degradation of BimEL in Cancer Cells
Zhang, W., Cheng, G. Z., Gong, J., Hermanto, U., Zong, C. S., Chan, J. L. ‐., Cheng, J. Q., & Wang, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802360200 · Cited by 74
Taxol: Mechanisms of action against cancer, an update with current research
Lim, P. T., Goh, B. H., & Lee, W.-L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90951-8.00007-2 · Cited by 74
Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance
Zhao, F., & Lam, E. W. ‐. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0228-0 · Cited by 74
Self-citationTF-DUBTACs Stabilize Tumor Suppressor Transcription Factors
Liu, J., Yu, X., Chen, H., Kaniskan, H. Ü., Xie, L., Chen, X., Jin, J., & Wei, W. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c04824 · Cited by 73
Lü, Q., Zhai, Y., Cheng, Q., Liu, Y., Gao, X., Zhang, T., Wei, Y., Zhang, F., & Yin, X. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.068361 · Cited by 73
Feroze-Zaidi, F., Fusi, L., Takano, M., Higham, J., Salker, M. S., Goto, T., Edassery, S., Klingel, K., Boini, K. M., Palmada, M., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0659 · Cited by 73
Self-citationReal, P. J., Benito, A., Cuevas, J., Berciano, M. T., de Juan, A., Coffer, P., Gomez-Roman, J., Lafarga, M., Lopez-Vega, J. M., & Fernandez-Luna, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1134 · Cited by 72
Self-citationCBP-Mediated FOXO-1 Acetylation Inhibits Pancreatic Tumor Growth by Targeting SirT
Pramanik, K. C., Fofaria, N. M., Gupta, P., & Srivastava, S. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0863 · Cited by 72
The Forkhead factor FoxQ1 influences epithelial differentiation
Feuerborn, A., Srivastava, P. K., Küffer, S., Grandy, W. A., Sijmonsma, T., Gretz, N., Brors, B., & Gröne, H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22385 · Cited by 72
Wu, W., Zou, M., Brickley, D. R., Pew, T., & Conzen, S. D. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0131 · Cited by 71
Foxo3a Expression Is a Prognostic Marker in Breast Cancer
Jiang, Y., Zou, L., Lu, W., Zhang, Y., & Shen, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070746 · Cited by 71
Chong, Z., Li, F., & Maiese, K. (2006) · Current Neurovascular Research · doi:10.2174/156720206776875830 · Cited by 71
FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis
Song, Y., Zeng, S., Zheng, G., Chen, D., Li, P., Yang, M., Luo, K., Yin, J., Gu, Y., Zhang, Z., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01562-y · Cited by 71
Hypoxia Suppression of Bim and Bmf Blocks Anoikis and Luminal Clearing during Mammary Morphogenesis
Whelan, K. A., Caldwell, S. A., Shahriari, K. S., Jackson, S. R., Franchetti, L. D., Johannes, G. J., & Reginato, M. J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-04-0353 · Cited by 70
Yang, J.-Y., Chang, C.-J., Xia, W., Wang, Y., Wong, K.-K., Engelman, J. A., Du, Y., Andreeff, M., Hortobagyi, G. N., & Hung, M.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4524 · Cited by 69
PINK1 signalling in cancer biology
O’Flanagan, C. H., & O’Neill, C. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.006 · Cited by 69
Nasimian, A., Farzaneh, P., Tamanoi, F., & Bathaie, S. Z. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113999 · Cited by 69
Tat-Induced FOXO3a Is a Key Mediator of Apoptosis in HIV-1-Infected Human CD4+ T Lymphocytes
Dabrowska, A., Kim, N., & Aldovini, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8460 · Cited by 68
TAT-Bim Induces Extensive Apoptosis in Cancer Cells
Kashiwagi, H., McDunn, J. E., Goedegebuure, P. S., Gaffney, M. C., Chang, K. C., Trinkaus, K. M., Piwnica-Worms, D. R., Hotchkiss, R. S., & Hawkins, W. G. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9298-z · Cited by 68
MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma
Wu, C., Jin, B., Chen, L., Zhuo, D., Zhang, Z., Gong, K., & Mao, Z. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.028 · Cited by 68
FOXO3 is essential for CD44 expression in pancreatic cancer cells
Kumazoe, M., Takai, M., Bae, J., Hiroi, S., Huang, Y., Takamatsu, K., Won, Y., Yamashita, M., Hidaka, S., Yamashita, S., et al. (2016) · Oncogene · doi:10.1038/onc.2016.426 · Cited by 67
Hallaert, D. Y. H., Spijker, R., Jak, M., Derks, I. A. M., Alves, N. L., Wensveen, F. M., de Boer, J. P., de Jong, D., Green, S. R., van Oers, M. H. J., et al. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402211 · Cited by 66
Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A
Bertoli, C., Copetti, T., Lam, E. W. ‐., Demarchi, F., & Schneider, C. (2008) · Oncogene · doi:10.1038/onc.2008.425 · Cited by 66
Self-citationmiRNAs in breast cancer tumorigenesis (Review)
ZHANG, Z. J., & Shi, L. (2011) · Oncology Reports · doi:10.3892/or.2011.1611 · Cited by 66
Li, L., Ji, S., Yang, J., Li, X., Zhang, J., Zhang, Y., Hu, Z., & Liu, Y. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.007 · Cited by 66
Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma
Zhang, Z.-C., Li, Y.-Y., Wang, H., Fu, S., Wang, X.-P., Zeng, M., Zeng, Y., & Shao, J.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086149 · Cited by 66
Marine compounds targeting the PI3K/Akt signaling pathway in cancer therapy
Wei, J., Gou, Z., Wen, Y., Luo, Q., & Huang, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110484 · Cited by 66
Jeung, Y. S., Kim, H., Ahn, J., Lee, H., Lee, S.-B., Won, M., Jung, C.-R., Im, J., Kim, B., Park, S., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.07.005 · Cited by 65
Reagan‐Shaw, S., & AHMAD, N. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.003 · Cited by 65
Finnberg, N. K., & El‐Deiry, W. S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.7.1057 · Cited by 65
Leao, M., Anderton, E., Wade, M. R., Meekings, K. N., & Allday, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.01096-06 · Cited by 64
Regulation of Ubiquitination-Mediated Protein Degradation by Survival Kinases in Cancer
Yamaguchi, H., Hsu, J. L., & Hung, M. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00015 · Cited by 64
Apoptosis induction by eIF5A1 involves activation of the intrinsic mitochondrial pathway
Sun, Z., Cheng, Z., Taylor, C. A., McConkey, B. J., & Thompson, J. E. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22100 · Cited by 64
Matsuda, F., Inoue, N., Maeda, A., CHENG, Y., Sai, T., Gonda, H., Goto, Y., Sakamaki, K., & MANABE, N. (2010) · Journal of Reproduction and Development · doi:10.1262/jrd.10-124h · Cited by 64
Apoptosis induced by overall metabolic stress converges on the Bcl-2 family proteins Noxa and Mcl-1
Wensveen, F. M., Alves, N. L., Derks, I. A. M., Reedquist, K. A., & Eldering, E. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0599-8 · Cited by 62
Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update
Thiruvengadam, M., Khalil, A. A., Rauf, A., Alhumaydhi, F. A., Aljohani, A. S. M., Javed, M. S., Khan, M. A., Khan, I. A., El-Esawi, M. A., Bawazeer, S., et al. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221102155212 · Cited by 62
Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach
Trendowski, M. R. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.09.007 · Cited by 62
Kfir‐Erenfeld, S., Sionov, R. V., Spokoini, R., Cohen, O., & Yefenof, E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.506570 · Cited by 61
Yu, T., Ji, J., & Guo, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.008 · Cited by 61
Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy
Senapati, D., Patra, B. C., Kar, A., Chini, D. S., Ghosh, S., Patra, S., & Bhattacharya, M. (2019) · Gene · doi:10.1016/j.gene.2019.144071 · Cited by 60
Liu, H., Zhou, B.-H., Qiu, X., Wang, H., Zhang, F., Fang, R., Wang, X., Cai, S., Du, J., & Bu, X. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.537 · Cited by 60
Guduru, R., & Khizroev, S. (2013) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201300238 · Cited by 60
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo
Park, S., Chung, Y. M., Ma, J., Yang, Q., Berek, J. S., & Hu, M. C. ‐. (2016) · Oncotarget · doi:10.18632/oncotarget.9881 · Cited by 60
Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor
Miller, A. V., Hicks, M. A., Nakajima, W., Richardson, A. C., Windle, J. J., & Harada, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060685 · Cited by 60
Kong, W., Li, C., Qi, Q., Shen, J., & Chang, K. (2019) · Cell Biology International · doi:10.1002/cbin.11217 · Cited by 60
Zhang, Y., Moszczynski, L. A., Liu, Q., Jiang, J., Zhao, D., Quan, D., Mele, T. S., McAlister, V. C., Jevnikar, A. M., Baek, S. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16607 · Cited by 59
Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells
Yang, W. P., Monroe, J. D., Zhang, Y., George, D. W., BREMER, E., & Li, H. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.033 · Cited by 59
Promises of Apoptosis-Inducing Peptides in Cancer Therapeutics
Barras, D., & Widmann, C. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111796117337 · Cited by 59
Kim, N., Kukkonen, S. K. J., Gupta, S., & Aldovini, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001103 · Cited by 59
Wykosky, J., Hu, J., Gomez, G. G., Taylor, T. E., Villa, G. R., Pizzo, D. P., VandenBerg, S. R., Thorne, A. H., Chen, C. C., Mischel, P. S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2004 · Cited by 58
FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis
Wang, J., Liu, S., Yin, Y., Li, M., Wang, B., Yang, L., & Jiang, Y. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1071-3 · Cited by 58
Alonso, R., López‐Guerra, M., Upshaw, R., Bantia, S., Smal, C., Bontemps, F., Manz, C. Y., Mehrling, T., Villamor, N., Campo, E., et al. (2009) · Blood · doi:10.1182/blood-2009-02-207654 · Cited by 57
Yuan, Z., Wang, F., Zhao, Z., Zhao, X., Qiu, J., Nie, C., & Wei, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020586 · Cited by 57
Li, J., Li, P., Chen, T., Gao, G., Chen, X., Du, Y., Zhang, R., Yang, R., Zhao, W., Dun, S., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2698-y · Cited by 57
He, L., YANG, X., Cao, X., LIU, F., Quan, M., & Cao, J. (2012) · Oncology Reports · doi:10.3892/or.2012.2076 · Cited by 57
FOXO1A Is a Target for HER2-Overexpressing Breast Tumors
Wu, Y., Shang, X., Sarkissyan, M., Slamon, D. J., & Vadgama, J. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0176 · Cited by 56
Metadata
- Authors
- Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F.
- Affiliations
- Cancer Research UK (GB)
- The Netherlands Cancer Institute (NL)
- Hammersmith Hospital (GB)
- University Medical Center Utrecht (NL)
- Corresponding author
- Lam, Eric W.-F.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 50
- Pages
- 49795-49805
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1422650632
- Cited by
- 505
- References
- 52
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 19 · 2022: 9 · 2021: 14 · 2020: 22 · 2019: 27 · 2018: 16 · 2017: 24 · 2016: 10 · 2015: 27 · 2014: 34 · 2013: 39 · 2012: 32
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6139 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- RVC Research Online (Royal Veterinary College) (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- FOXO3, building information modeling, apoptosis, paclitaxel, breast cancer, FOXO transcription factors, transcriptional regulation, MCF-7 cells, MDA-MB-231 cells, drug resistance, siRNA knockdown
- MeSH terms
- Forkhead Box Protein O1, Bcl-2-Like Protein 11, Antineoplastic Agents, Phytogenic, Binding Sites, Breast Neoplasms, Carrier Proteins, Cell Line, DNA-Binding Proteins, Humans, Membrane Proteins, Mitosis, Promoter Regions, Genetic, Proto-Oncogene Proteins, RNA, Messenger, Time Factors, Transcription Factors, Transcription, Genetic, Transfection, Blotting, Western, Up-Regulation, Gene Expression Regulation, Neoplastic, G2 Phase, Apoptosis, Paclitaxel, Annexin A5, Genes, Reporter, Reverse Transcriptase Polymerase Chain Reaction, RNA, Small Interfering, Cell Line, Tumor, Apoptosis Regulatory Proteins, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.